InvestorsHub Logo
Followers 28
Posts 12075
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Monday, 03/08/2021 11:54:10 AM

Monday, March 08, 2021 11:54:10 AM

Post# of 7485
Is this competition for Avita;

More recently, Mallinckrodt revealed it would have to wait a bit longer for an FDA decision on its regenerative skin tissue therapy StrataGraft, after COVID-19 delays derailed the timeline for a manufacturing plant inspection. The FDA was originally due to make a decision on StrataGraft on Feburary 2.

https://www.fiercepharma.com/manufacturing/fda-s-inspection-woes-to-grow-if-agency-doesn-t-address-covid-19-backlog-gao

"The Investors's Chief Problem--and even his worst enemy--is likely to be himself"
---Benjamin Graham

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News